U.S. markets close in 3 hours 26 minutes

Bio-Techne Rebrands Atlanta Biologicals Serum And Media As Part Of The R&D Systems Product Portfolio

MINNEAPOLIS, Jan. 7, 2020 /PRNewswire/ -- Bio-Techne Corporation (NASDAQ: TECH) today announced that the Atlanta Biologicals portfolio of serum and media will be rebranded as R&D Systems. As part of the rebranding, the Atlanta Biologicals website will be retired and the entire serum and media portfolio, including product details and purchasing options, will be maintained through the R&D Systems website. Currently all serum and media products can be purchased through R&D Systems.

Dave Eansor, President of Bio-Techne's Protein Sciences Segment, commented, "We are excited to consolidate the Atlanta Biologicals portfolio within R&D Systems' extended offering of cell culture solutions. By rolling the Atlanta Biologicals brand into R&D Systems, researchers will benefit from ensured product quality, an expanded portfolio of culture regents and an experience that enables the purchase of media, serum, proteins, antibodies, and more from a single, trusted source."

More information on the rebranding and retirement of Atlanta Biologicals can be found at https://www.rndsystems.com/atlanta-biologicals-now-rd-systems

About Bio-Techne Corporation (NASDAQ: TECH)

Contact: 

David Clair, Senior Director, Corporate Development


david.clair@bio-techne.com


612-656-4416 

 

Bio-Techne

 

Cision

View original content to download multimedia:http://www.prnewswire.com/news-releases/bio-techne-rebrands-atlanta-biologicals-serum-and-media-as-part-of-the-rd-systems-product-portfolio-300979866.html

SOURCE Bio-Techne Corporation